Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Where To Find Index Level Data
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesDid $1,000? Broadcom's Guidance Created AI Buy Opportunity
When Broadcom's guidance disappointed, a sudden market pullback opened a legitimate AI buying opportunity. This artic...
Elon Musk's SpaceX Wants to Launch AI Compute Satellites
SpaceX aims to put AI compute in orbit by 2028, a move that could reshape data centers. This article breaks down the ...
Trillion Reasons Nvidia Phenomenal Stock Buy Right Now
Nvidia is not just riding the AI wave—it's shaping it. This article explains why trillion reasons nvidia phenomenal, ...
Trump Again Pushes Powell to Cut Rates, Markets Brace
As oil prices surge toward triple digits, Trump volleyed calls for immediate rate cuts from Powell. The Fed appears p...
Degrees Still Shield Workers From Unemployment in 2026
Fresh federal data for early 2026 confirm that graduates with a bachelor’s degree face the lowest unemployment rates,...
Housing Demand Stays Positive as Rates Near 2026 Highs
Despite rates at year-to-year highs, housing demand stays positive as weekly data on pending sales and mortgage appli...
Famous Tech Investor Lee Signals Buy After Chip Selloff
Semiconductors led by the SMH and SOXX pulled back sharply, triggering fresh talk of a buyable dip. Famous tech inves...
Housing Permits Near Cycle Lows Clash with Starts Today
June data reveal a surprising split: housing starts topped expectations while housing permits near cycle lows, hintin...
Symbotic Insider Sells 8,306: What It Means for Investors
A corporate insider recently sold a sizable block of Symbotic stock. This article breaks down what the sale means, ho...
Micron Price Prediction: Wedbush Lifts Target to $500
Wedbush boosts its Micron price target to $500, arguing demand remains healthy after the Chinese New Year. The upgrad...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status